An anchored matching-adjusted indirect comparison of fixed-dose combination calcipotriol and betamethasone dipropionate (Cal/BDP) cream versus Cal/BDP foam for the treatment of psoriasis.

Anthony BewleyErin BarkerHannah BakerWill GreenBrooke AveyAina Pi-BlanqueJordi GalvánPaw TrebbienMorten Praestegaard

Published in: The Journal of dermatological treatment (2022)

Cal/BDP cream and Cal/BDP foam have equivalent efficacy and HRQoL (measured in DLQI) outcomes when used for the topical treatment of plaque psoriasis at their recommended treatment durations. A comparison of treatment satisfaction assessments after 1 week of treatment demonstrated that patients find Cal/BDP cream to be more convenient than foam.

Keyphrases

metabolic syndrome
coronary artery disease
adipose tissue
replacement therapy
patient reported outcomes